SJ Payne, RL Bowen, JL Jones, CA Wells - Histopathology, 2008 - interscience.wiley.com Breast cancer is a heterogeneous disease and there is a continual drive to
identify markers that will aid in predicting prognosis and response to therapy.
To date, relatively few markers have established prognostic power. ... Cited by 22 - Related articles - BL Direct - All 3 versions
- ►aspetjournals.org N Kumar, R Afeyan, HD Kim, DA … - Molecular pharmacology, 2008 - ASPET Small-molecule kinase inhibitors often modulate signaling pathways other than
the one targeted, whether by direct "off-target" effects or by indirect "pathway
cross-talk" effects. The presence of either or both of these classes of ... Cited by 10 - Related articles - All 5 versions
D Gurwitz, E Zika, MM Hopkins, S Gaisser, D … - Public Health Genomics, 2009 - content.karger.com This paper reviews the current situation in the field of
pharmacogenetics/pharmacogenomics (PGx) in Europe. High expectations surrounding
the clinical application of PGx remain largely unmet, as only a limited ... Cited by 3 - Related articles - All 4 versions
KICTE ON, M OF - assets0.pubget.com Page 1. MOL 43794 1 MULTI-PATHWAY MODEL ENABLES PREDICTION OF KINASE INHIBITOR
CROSS-TALK EFFECTS ON MIGRATION OF HER2-OVEREXPRESSING MAMMARY EPITHELIAL CELLS ... Related articles - View as HTML
GSS Ramos - infarmate.org Con las investigaciones derivadas del Proyecto del Genoma Humano se ha visto
favorecido el desarrollo de farmacoterapias más personalizadas. La
Farmacogenética se ha desarrollado a grandes pasos en los últimos años ... Related articles - View as HTML